Clinical Trial Update: Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the incidence of deep vein thrombosis after administration of recombinant human antithrombin in patients with hereditary antithrombin de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Deficiency

Drugs mentioned

• Recombinant human antithrombin (antithrombin)

Snippet

Sponsor: rEVO Biologics | Conditions: Antithrombin Deficiency, Congenital | Phase 3 | Status: COMPLETED | Results posted: 2012-10-16